LTBK-12. EORTC 26951, RANDOMIZED STUDY OF ADJUVANT PCV AFTER 59.4 GY RADIOTHERAPY: VERY LONG TERM FOLLOW-UP

BACKGROUND: Between 1995 and 2002 the EORTC Brain Tumor Group conducted a prospective phase III study on adjuvant procarbazine, CCNU and vincristine (PCV) chemotherapy in anaplastic oligodendroglioma (AOD). A mature follow-up presented in 2012 showed survival benefit of the addition of PCV, in parti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: van den Bent, Martin, Hoang-Xuan, Khe, Brandes, Alba, Kros, Johan, Kouwenhoven, M C M, Taphoorn, Martin, Delattre, Jean-Yves, Bernsen, Hans, Frenay, Marc, Synhaeve, Nathalie, Weller, Michael, Enting, Roelien, French, Pim, Dinjens, Winand, Golfinopoulos, Vassilis, Gorlia, Thierry
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Late Breaking Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6873623/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz219.1201
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados